Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Blog
Podcast
Product Guide
Career Quest
Drug Approval
Blog Post
MDA Ambassador Guest Blog: Finding Hope and Optimism in New Treatments
By
Chase Rankin
|
June 4, 2024
Blog Post
In Case You Missed It…
By
MDA Staff
|
April 8, 2024
Blog Post
FDA’s Approval of Duvyzat (givinostat) Offers New Hope to People Living with Duchenne Muscular Dystrophy
By
MDA Staff
|
March 21, 2024
Blog Post
Celebrating Our 2023 Advocacy Accomplishments
By
Mark Fisher
|
December 20, 2023
Blog Post
2023 in Review: A Letter from MDA President and CEO, Dr. Wood
By
Donald S. Wood, Ph.D., President and CEO, Muscular Dystrophy Association
|
December 11, 2023
Featured Article
Q&A: Understanding Metabolic Myopathies
By
MDA Staff
|
November 17, 2023
Blog Post
In Case You Missed It…
By
MDA Staff
|
November 8, 2023
Blog Post
AGAMREE ® (Vamorolone), Now FDA-Approved, Offers Hope for Children Living with Duchenne Muscular Dystrophy
By
MDA Staff
|
October 26, 2023
Featured Article
Advances in the Treatment of Friedreich Ataxia
By
MDA Staff
|
August 8, 2023
Blog Post
DMD Gene Therapy Approval Ignites Hope
By
Larry Luxner
|
August 1, 2023
1
2
3
…
5
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset